High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$422K
$422,980
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| DAWN |
Day One Biopharmaceuticals, Inc.
|
CEO
Discretionary Sell
|
2026-02-17 | $179,338 | S | Form 4 |
|
DAWN
S
Day One Biopharmaceuticals, Inc.
Dubow Adam
• Officer • Gen Counsel & Secretary
Discretionary Sell
2026-02-17
$74,188
|
||||||
| DAWN |
Day One Biopharmaceuticals, Inc.
|
Officer • Gen Counsel & Secretary
Discretionary Sell
|
2026-02-17 | $74,188 | S | Form 4 |
|
DAWN
S
Day One Biopharmaceuticals, Inc.
Merendino Lauren
• Officer • Chief Commercial Officer
Discretionary Sell
2026-02-17
$67,448
|
||||||
| DAWN |
Day One Biopharmaceuticals, Inc.
|
Officer • Chief Commercial Officer
Discretionary Sell
|
2026-02-17 | $67,448 | S | Form 4 |
|
DAWN
S
Day One Biopharmaceuticals, Inc.
VASCONCELLES MICHAEL
• Officer • Head of Research and Dev.
Discretionary SellΔOwn -38.3%
2026-02-17
$31,647
|
||||||
| DAWN |
Day One Biopharmaceuticals, Inc.
|
Officer • Head of Research and Dev.
Discretionary SellΔOwn -38.3%
|
2026-02-17 | $31,647 | S | Form 4 |
|
DAWN
S
Day One Biopharmaceuticals, Inc.
York Charles N II
• CFO
Discretionary Sell
2026-02-17
$70,359
|
||||||
| DAWN |
Day One Biopharmaceuticals, Inc.
|
CFO
Discretionary Sell
|
2026-02-17 | $70,359 | S | Form 4 |